Amy Earley

7.3k total citations · 2 hit papers
41 papers, 2.3k citations indexed

About

Amy Earley is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Amy Earley has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Economics and Econometrics. Recurrent topics in Amy Earley's work include Chronic Kidney Disease and Diabetes (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Dialysis and Renal Disease Management (5 papers). Amy Earley is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Dialysis and Renal Disease Management (5 papers). Amy Earley collaborates with scholars based in United States, Brazil and Canada. Amy Earley's co-authors include Ethan M. Balk, Katrin Uhlig, Ashish Upadhyay, Shana M Haynes, Edmund J. Lamb, Dana C. Miskulin, Andrew S. Levey, Thomas A Trikalinos, Anastassios G. Pittas and Patrick Remington and has published in prestigious journals such as Annals of Internal Medicine, Cochrane Database of Systematic Reviews and Kidney International.

In The Last Decade

Amy Earley

38 papers receiving 2.2k citations

Hit Papers

Global dietary calcium intake among adults: a systematic ... 2017 2026 2020 2023 2017 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Earley United States 20 648 566 430 352 288 41 2.3k
Mustafa Arıcı Türkiye 24 644 1.0× 680 1.2× 378 0.9× 183 0.5× 333 1.2× 146 2.4k
Manish D. Sinha United Kingdom 25 934 1.4× 735 1.3× 450 1.0× 171 0.5× 374 1.3× 156 2.9k
Michał Nowicki Poland 27 557 0.9× 761 1.3× 483 1.1× 449 1.3× 179 0.6× 221 2.9k
Amy Luke United States 25 616 1.0× 522 0.9× 483 1.1× 438 1.2× 324 1.1× 37 2.8k
Gültekin Süleymanlar Türkiye 26 480 0.7× 746 1.3× 480 1.1× 136 0.4× 236 0.8× 128 2.3k
Menno Pruijm Switzerland 32 481 0.7× 894 1.6× 377 0.9× 447 1.3× 204 0.7× 176 3.0k
James B. Wetmore United States 27 521 0.8× 1.2k 2.1× 435 1.0× 132 0.4× 314 1.1× 137 2.9k
Adrian Covic Romania 30 649 1.0× 1.3k 2.2× 492 1.1× 214 0.6× 177 0.6× 127 3.1k
Michele Provenzano Italy 29 500 0.8× 953 1.7× 424 1.0× 457 1.3× 137 0.5× 134 2.3k
Chi-Pang Wen Taiwan 14 540 0.8× 932 1.6× 276 0.6× 466 1.3× 213 0.7× 14 2.5k

Countries citing papers authored by Amy Earley

Since Specialization
Citations

This map shows the geographic impact of Amy Earley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Earley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Earley more than expected).

Fields of papers citing papers by Amy Earley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Earley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Earley. The network helps show where Amy Earley may publish in the future.

Co-authorship network of co-authors of Amy Earley

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Earley. A scholar is included among the top collaborators of Amy Earley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Earley. Amy Earley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Floege, Jürgen, Keisha L. Gibson, Marina Vivarelli, et al.. (2025). Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children. Kidney International. 107(5). 806–808. 2 indexed citations
2.
Floege, Jürgen, David Jayne, Jan‐Stephan Sanders, et al.. (2024). Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis. Kidney International. 105(3). 447–449. 20 indexed citations
3.
Awan, Ahmed A., Marina Berenguer, Annette Bruchfeld, et al.. (2023). Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline. Annals of Internal Medicine. 176(12). 1648–1655. 5 indexed citations
4.
Martin, Paul, Ahmed A. Awan, Marina Berenguer, et al.. (2022). Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International. 102(6). 1228–1237. 20 indexed citations
5.
Tomson, Charles, Alfred K. Cheung, Johannes F.E. Mann, et al.. (2021). Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Annals of Internal Medicine. 174(9). 1270–1281. 36 indexed citations
6.
Cheung, Alfred K., Tara I. Chang, William C. Cushman, et al.. (2021). Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International. 99(3). 559–569. 176 indexed citations breakdown →
7.
Mann, Johannes F.E., Tara I. Chang, William C. Cushman, et al.. (2021). Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Current Cardiology Reports. 23(9). 132–132. 11 indexed citations
8.
Lópes, Renato D., Samantha Berger, Manuela Di Fusco, et al.. (2020). A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation. International Journal of Cardiology. 319. 85–93. 5 indexed citations
9.
Chadban, Steven J., Curie Ahn, David A. Axelrod, et al.. (2020). Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 104(4). 708–714. 91 indexed citations
10.
Gordon, Craig E., Marina Berenguer, Wahid Doss, et al.. (2019). Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline. Annals of Internal Medicine. 171(7). 496–504. 14 indexed citations
11.
Jadoul, Michel, Marina Berenguer, Wahid Doss, et al.. (2018). Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney International. 94(4). 663–673. 48 indexed citations
12.
Balk, Ethan M., Gaelen P. Adam, Valerie Langberg, et al.. (2018). Correction to: Global dietary calcium intake among adults: a systematic review. Osteoporosis International. 29(5). 1223–1223. 7 indexed citations
13.
Burnett, Heather, Amy Earley, Adriaan A. Voors, et al.. (2017). Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction. Circulation Heart Failure. 10(1). 166 indexed citations
14.
Balk, Ethan M., Gaelen P. Adam, Valerie Langberg, et al.. (2017). Global dietary calcium intake among adults: a systematic review. Osteoporosis International. 28(12). 3315–3324. 281 indexed citations breakdown →
15.
Earley, Amy, et al.. (2014). Fluorescence In Situ Hybridization Testing for the Diagnosis of High-Grade Cervical Abnormalities. Journal of Lower Genital Tract Disease. 18(3). 218–227. 7 indexed citations
16.
Earley, Amy, Rebecca Persson, Ann C. Garlitski, Ethan M. Balk, & Katrin Uhlig. (2014). Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in Subgroups. Annals of Internal Medicine. 160(2). 111–121. 27 indexed citations
17.
Earley, Amy, Joseph Lau, & Katrin Uhlig. (2013). Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications–a cross-sectional study. BMJ Open. 3(1). e001963–e001963. 24 indexed citations
18.
Deo, Aneet, Christopher H. Schmid, Amy Earley, Joseph Lau, & Katrin Uhlig. (2011). Loss to Analysis in Randomized Controlled Trials in CKD. American Journal of Kidney Diseases. 58(3). 349–355. 22 indexed citations
19.
Uhlig, Katrin, Amy Earley, & Christopher H. Schmid. (2011). In Reply to ‘Misuse and Reporting of Renal Endpoints in Randomized Clinical Trials’. American Journal of Kidney Diseases. 59(1). 160–161. 1 indexed citations
20.
Earley, Amy, et al.. (1989). “Balances” and “safety nets”. BMJ. 299(6707). 1103.3–1103.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026